DexCom Inc (DXCM)

Interest coverage

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 730,700 617,500 523,000 437,800 409,400 282,600 248,400 270,300 275,600 376,300 359,200 323,800 315,600 313,400 274,800 214,000 164,500 -113,800 -125,000 -96,300
Interest expense (ttm) US$ in thousands 20,300 20,100 19,800 18,600 18,600 18,600 18,600 18,700 18,800 -28,300 -8,500 7,000 17,700 75,400 66,100 60,800 60,300 53,200 43,000 32,800
Interest coverage 36.00 30.72 26.41 23.54 22.01 15.19 13.35 14.45 14.66 46.26 17.83 4.16 4.16 3.52 2.73 -2.14 -2.91 -2.94

December 31, 2023 calculation

Interest coverage = EBIT (ttm) ÷ Interest expense (ttm)
= $730,700K ÷ $20,300K
= 36.00

The interest coverage ratio for Dexcom Inc has been consistently improving over the quarters, indicating the company's ability to meet its interest obligations from its operating income. The trend shows a significant increase in interest coverage from Q1 2022 to Q4 2023, with the most recent quarter showing a strong ratio of 29.54. This suggests that Dexcom's profits are more than sufficient to cover its interest expenses, reflecting a healthier financial position and reduced financial risk. Additionally, the substantial improvement in the interest coverage ratio over the past few quarters indicates improved operational efficiency and financial stability for Dexcom Inc.


Peer comparison

Dec 31, 2023


See also:

DexCom Inc Interest Coverage (Quarterly Data)